相似文献
1
The role of N53Q mutation on the rat mu-opioid receptor function.
J Biomol Tech. 2010 Jul;21(2):92-6.
2
STAT5A interacts with and is phosphorylated upon activation of the mu-opioid receptor.
J Neurochem. 2005 May;93(4):918-31. doi: 10.1111/j.1471-4159.2005.03069.x.
3
Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204. doi: 10.1016/s0169-328x(99)00241-7.
4
Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
J Biol Chem. 2009 Jul 3;284(27):18357-67. doi: 10.1074/jbc.M109.015453. Epub 2009 May 5.
5
[Expression of human mu-opioid receptor cDNA in CHO cell].
Sheng Wu Gong Cheng Xue Bao. 2004 May;20(3):372-6.
6
Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene.
J Immunol. 2003 May 15;170(10):5118-23. doi: 10.4049/jimmunol.170.10.5118.
7
MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway.
FEBS Lett. 1999 Jul 30;456(1):196-200. doi: 10.1016/s0014-5793(99)00949-7.
8
Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias.
Neuropharmacology. 2017 May 15;118:46-58. doi: 10.1016/j.neuropharm.2017.03.007. Epub 2017 Mar 7.
9
Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.
J Biol Chem. 1995 Dec 15;270(50):29732-8. doi: 10.1074/jbc.270.50.29732.
10
Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Synapse. 2004 Jun 1;52(3):209-17. doi: 10.1002/syn.20019.
引用本文的文献
1
Opioid receptor desensitization: mechanisms and its link to tolerance.
Front Pharmacol. 2014 Dec 18;5:280. doi: 10.3389/fphar.2014.00280. eCollection 2014.
本文引用的文献
1
Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor.
Biochem J. 2005 Aug 15;390(Pt 1):367-76. doi: 10.1042/BJ20050189.
2
Opioids: cellular mechanisms of tolerance and physical dependence.
Curr Opin Pharmacol. 2005 Feb;5(1):60-8. doi: 10.1016/j.coph.2004.08.012.
3
N-linked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expression.
FEBS Lett. 2004 Mar 26;562(1-3):111-7. doi: 10.1016/S0014-5793(04)00191-7.
4
Cannabinoids and opioids share cAMP pathway in rat splenocytes.
J Neuroimmunol. 2003 Dec;145(1-2):46-54. doi: 10.1016/j.jneuroim.2003.09.006.
5
Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening.
BMC Pharmacol. 2003 Dec 1;3:14. doi: 10.1186/1471-2210-3-14.
6
The role of N-linked glycosylation in determining the surface expression, G protein interaction and effector coupling of the alpha (alpha) isoform of the human thromboxane A(2) receptor.
Biochim Biophys Acta. 2003 May 2;1621(2):192-203. doi: 10.1016/s0304-4165(03)00059-x.
7
Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor.
Biochem Biophys Res Commun. 2003 Feb 14;301(3):693-8. doi: 10.1016/s0006-291x(03)00023-8.
8
Functional role of N-linked glycosylation on the rat melanin-concentrating hormone receptor 1.
FEBS Lett. 2003 Jan 2;533(1-3):29-34. doi: 10.1016/s0014-5793(02)03744-4.
9
Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
J Neurochem. 2002 Nov;83(4):818-27. doi: 10.1046/j.1471-4159.2002.01188.x.
10
Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.
Biochem Pharmacol. 2002 Jul 15;64(2):257-66. doi: 10.1016/s0006-2952(02)01114-0.
Zotero 插件